Verbatim fundamentals
PATH Reported Quarterly Fundamentals
Quarterly reported revenue and EPS come from Verbatim with FMP income-statement actuals as a bounded fallback. Enterprise value is computed as market cap plus net debt using Verbatim shares, cash, debt, and the latest available close on or before each fiscal quarter end.
Symbol
PATH
Latest Revenue
$316.25M
Latest EPS
0.15
Latest EV
$4.13B
Actual and valuation coverage
154/154 (100%)
Consensus EPS coverage
44/44 (100%)
PATH Historical EPS and Surprise
Historical EPS and surprise data use all Verbatim reported quarters available for the symbol.
PATH EPS Surprise Percentage
Reported EPS versus consensus estimate, shown as percentage beat or miss by quarter with rolling 3-year statistical bands.
Quarterly EPS: Estimated vs Reported
Historical Quarterly Earnings - PATH
Showing 22 quarters of earnings data from Q1 2021 to Q2 2026
PATH Reported Quarters (22)
Showing all Verbatim reported quarters available for the symbol. EV uses the latest available close and latest Verbatim balance-sheet snapshot on or before each fiscal quarter end.
| Fiscal Quarter | Reported | Revenue | EPS | EPS Est. | Surprise % | Close | Shares | Market Cap | Net Debt | EV | Sources |
|---|---|---|---|---|---|---|---|---|---|---|---|
2026-04-30 Q2 - balance 2026-04-30 | 2026-05-28 | $316.25M | 0.15 | 0.15 | -3.2 | $10.30 2026-04-30 | 528M | $5.44B | -$1.31B | $4.13B | alpha-vantage, sec-xbrl |
2026-01-31 Q1 - balance 2026-01-31 | 2026-03-11 | $335.11M | 0.30 | 0.26 | 17.3 | $12.59 2026-01-30 | 545M | $6.86B | -$1.47B | $5.39B | alpha-vantage, sec-xbrl |
2025-10-31 Q4 - balance 2025-10-31 | 2025-12-03 | $526.85M | 0.16 | 0.15 | 6.7 | $15.86 2025-10-31 | 539M | $8.55B | -$1.40B | $7.15B | alpha-vantage, sec-xbrl |
2025-07-31 Q3 - balance 2025-07-31 | 2025-09-04 | $325.92M | 0.15 | 0.08 | 87.5 | $11.75 2025-07-31 | 543M | $6.38B | -$1.45B | $4.93B | alpha-vantage, sec-xbrl |
2025-04-30 Q2 - balance 2025-04-30 | 2025-05-29 | $287.31M | 0.11 | 0.10 | 10.0 | $11.94 2025-04-30 | 548M | $6.54B | -$1.56B | $4.99B | alpha-vantage, sec-xbrl |
2025-01-31 Q1 - balance 2025-01-31 | 2025-03-12 | $289.59M | 0.26 | 0.19 | 36.8 | $14.22 2025-01-31 | 560M | $7.96B | -$1.63B | $6.33B | alpha-vantage, sec-xbrl |
2024-10-31 Q4 - balance 2024-10-31 | 2024-12-05 | $558.04M | 0.11 | 0.07 | 57.1 | $12.36 2024-10-31 | 551M | $6.81B | -$1.57B | $5.24B | alpha-vantage, sec-xbrl |
2024-07-31 Q3 - balance 2024-07-31 | 2024-09-05 | $262.74M | 0.04 | 0.03 | 33.3 | $12.17 2024-07-31 | 568M | $6.91B | -$1.74B | $5.17B | alpha-vantage, sec-xbrl |
2024-04-30 Q2 - balance 2024-04-30 | 2024-05-29 | $242.22M | 0.13 | 0.12 | 8.3 | $18.97 2024-04-30 | 570M | $10.81B | -$1.94B | $8.88B | alpha-vantage, sec-xbrl |
2024-01-31 Q1 - balance 2024-01-31 | 2024-03-13 | $245.07M | 0.22 | 0.16 | 37.5 | $22.98 2024-01-31 | 564M | $12.96B | -$1.88B | $11.08B | alpha-vantage, sec-xbrl |
2023-10-31 Q4 - balance 2023-10-31 | 2023-11-30 | $308.55M | 0.12 | 0.07 | 71.4 | $15.53 2023-10-31 | 567M | $8.81B | -$1.82B | $6.99B | alpha-vantage, sec-xbrl |
2023-07-31 Q3 - balance 2023-07-31 | 2023-09-06 | $262.74M | 0.09 | 0.03 | 200.0 | $18.08 2023-07-31 | 563M | $10.18B | -$1.83B | $8.35B | alpha-vantage, sec-xbrl |
2023-04-30 Q2 - balance 2023-04-30 | 2023-05-24 | $242.22M | 0.11 | 0.02 | 450.0 | $14.08 2023-04-28 | 558M | $7.86B | -$1.78B | $6.08B | alpha-vantage, sec-xbrl |
2023-01-31 Q1 - balance 2023-01-31 | 2023-03-15 | $245.07M | 0.15 | 0.06 | 150.0 | $15.36 2023-01-31 | 548M | $8.42B | -$1.76B | $6.66B | alpha-vantage, sec-xbrl |
2022-10-31 Q4 - balance 2022-10-31 | 2022-12-01 | $289.70M | 0.05 | -0.03 | 266.7 | $10.86 2022-10-31 | 550M | $5.97B | -$1.68B | $4.30B | alpha-vantage, sec-xbrl |
2022-07-31 Q3 - balance 2022-07-31 | 2022-09-06 | $220.82M | -0.02 | -0.11 | 81.8 | $10.22 2022-07-29 | 546M | $5.58B | -$1.72B | $3.86B | alpha-vantage, sec-xbrl |
2022-04-30 Q2 - balance 2022-04-30 | 2022-06-01 | $195.52M | -0.03 | -0.05 | 40.0 | $10.74 2022-04-29 | 542M | $5.82B | -$1.79B | $4.02B | alpha-vantage, sec-xbrl |
2022-01-31 Q1 - balance 2022-01-31 | 2022-03-30 | $186.22M | 0.05 | 0.03 | 66.7 | $11.50 2022-01-31 | 455M | $5.23B | -$1.87B | $3.37B | alpha-vantage, sec-xbrl |
2021-10-31 Q4 - balance 2021-10-31 | 2021-12-08 | $207.88M | -0.23 | -0.04 | -485.0 | $12.29 2021-10-29 | 532M | $6.54B | -$1.88B | $4.66B | alpha-vantage, sec-xbrl |
2021-07-31 Q3 - balance 2021-07-31 | 2021-09-07 | $147.29M | 0.01 | -0.05 | 120.0 | $12.51 2021-07-30 | 527M | $6.59B | -$1.90B | $4.70B | alpha-vantage, sec-xbrl |
2021-04-30 Q2 - balance 2021-04-30 | 2021-06-08 | $139.38M | 0.02 | -0.05 | 140.0 | $13.80 2021-04-30 | 215M | $2.97B | -$1.88B | $1.09B | alpha-vantage, sec-xbrl |
2021-01-31 Q1 - balance 2021-01-31 | 2021-04-21 | $113.10M | 0.09 | 0.17 | -47.1 | $12.26 2021-01-29 | 168M | $2.06B | -$460.52M | $1.60B | alpha-vantage, sec-xbrl |